HK1018204A1 - A use of selegiline in the manufacture of a medicament for preventing or treating peripheral neuropathy - Google Patents
A use of selegiline in the manufacture of a medicament for preventing or treating peripheral neuropathyInfo
- Publication number
- HK1018204A1 HK1018204A1 HK99103182A HK99103182A HK1018204A1 HK 1018204 A1 HK1018204 A1 HK 1018204A1 HK 99103182 A HK99103182 A HK 99103182A HK 99103182 A HK99103182 A HK 99103182A HK 1018204 A1 HK1018204 A1 HK 1018204A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- selegiline
- medicament
- manufacture
- preventing
- peripheral neuropathy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1352096P | 1996-03-15 | 1996-03-15 | |
PCT/US1997/004584 WO1997033572A1 (fr) | 1996-03-15 | 1997-03-13 | Methode de prevention et de traitement de la neuropathie peripherique par administration de selegiline |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1018204A1 true HK1018204A1 (en) | 1999-12-17 |
Family
ID=21760384
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK99103182A HK1018204A1 (en) | 1996-03-15 | 1999-07-23 | A use of selegiline in the manufacture of a medicament for preventing or treating peripheral neuropathy |
Country Status (8)
Country | Link |
---|---|
US (4) | US6239181B1 (fr) |
EP (1) | EP0906090A1 (fr) |
JP (1) | JP3258027B2 (fr) |
CN (1) | CN1116870C (fr) |
AU (1) | AU709323B2 (fr) |
CA (1) | CA2244253C (fr) |
HK (1) | HK1018204A1 (fr) |
WO (1) | WO1997033572A1 (fr) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2284001A1 (fr) * | 1997-03-13 | 1998-09-17 | Keith Tipton | Agents cytoprotecteurs comprenant des inhibiteurs de monoamine-oxydase |
AU1080899A (en) | 1997-10-14 | 1999-05-03 | Nadine A. Tatton | Methods for increasing schwann cell survival |
US6809120B1 (en) * | 1998-01-13 | 2004-10-26 | University Of Saskatchewan Technologies Inc. | Composition containing propargylamine for enhancing cancer therapy |
BR9908713A (pt) | 1998-03-16 | 2000-11-21 | Somerset Pharmaceuticals Inc | Uso de selegilina ou desmetil-selegilina para tratamento de feridas, queimaduras e danos dermatológicos |
ATE499103T1 (de) * | 2000-07-07 | 2011-03-15 | Spectrum Pharmaceuticals Inc | Verfahren zur behandlung von arzneimittelinduzierter peripherer neuropathie und verwandten krankheitsformen |
DE60231896D1 (de) * | 2001-11-05 | 2009-05-20 | Krele Pharmaceuticals Llc | Zusammensetzungen und verfahren zur erhöhung der compliance mit therapien unter verwendung von aldehyddehydrogenase-hemmern und zur behandlung von alkoholsmus |
CN100506220C (zh) * | 2002-03-04 | 2009-07-01 | 萨默塞特医药公司 | 应用去甲司来吉兰制备预防和治疗周围神经病的药物 |
US6660736B2 (en) | 2002-03-27 | 2003-12-09 | Hoffmann-La Roche Inc. | Phthalimido derivatives and a process for their preparation |
PL373697A1 (en) | 2002-04-26 | 2005-09-05 | F.Hoffmann-La Roche Ag | Isoquinoline derivatives |
SI1511718T1 (sl) | 2002-05-29 | 2009-08-31 | Hoffmann La Roche | Derivati n-acilaminobenzena kot selektivni inhibitorji monoaminske oksidaze b |
US6900354B2 (en) | 2002-07-15 | 2005-05-31 | Hoffman-La Roche Inc. | 3-phenyl-propionamido, 3-phenyl-acrylamido and 3-phenyl-propynamido derivatives |
US6846832B2 (en) | 2002-08-07 | 2005-01-25 | Hoffman-La Roche Inc. | 2,3-dihydro-isoindol-1-one derivatives |
PE20050077A1 (es) | 2002-09-20 | 2005-03-01 | Hoffmann La Roche | Derivados de 4-pirrolidino-fenil-bencil-eter |
AU2003293798B8 (en) | 2002-12-13 | 2009-02-12 | F. Hoffmann-La Roche Ag | 3H-quinazolin-4-one derivatives |
US7148362B2 (en) | 2003-09-18 | 2006-12-12 | Hoffmann-La Roche Inc. | Process for the preparation of enantiopure pyrrolidin-2-one derivatives |
EP1680127B1 (fr) | 2003-10-23 | 2008-10-15 | F. Hoffmann-La Roche Ag | Derives de benzazepine utiles comme inhibiteurs de mao-b |
JP4427578B2 (ja) | 2004-06-23 | 2010-03-10 | エフ.ホフマン−ラ ロシュ アーゲー | 新規mao−bインヒビター |
BRPI0514077A (pt) | 2004-08-02 | 2008-05-27 | Hoffmann La Roche | derivados de benzilóxi como inibidores de maob |
CA2601416C (fr) | 2005-03-15 | 2013-07-09 | F. Hoffmann-La Roche Ag | Procede de preparation de derives ether 4-pyrrolidinophenylbenzylique purs sur le plan enantiomerique |
US7501528B2 (en) | 2005-03-15 | 2009-03-10 | Hoffmann-La Roche Inc. | Method for preparing enantiomerically pure 4-pyrrolidino phenylbenzyl ether derivatives |
AU2007327011A1 (en) * | 2006-11-30 | 2008-06-05 | Hunter-Fleming Limited | Modulation of prostaglandin/cyclooxygenase metabolic pathways |
AU2008345015A1 (en) * | 2007-12-27 | 2009-07-09 | Helicon Therapeutics, Inc. | Neurite outgrowth as an assay for memory enhancing compounds |
TW200936156A (en) | 2008-01-28 | 2009-09-01 | Novartis Ag | Methods and compositions using Klotho-FGF fusion polypeptides |
US8420088B2 (en) | 2008-01-28 | 2013-04-16 | Novartis Ag | Methods and compositions using FGF23 fusion polypeptides |
CN102137671B (zh) * | 2008-07-23 | 2012-10-17 | 国防教育研究基金会 | 含异烟碱酰胺(isoniazid,INH)低副作用的新复方 |
US20130165511A1 (en) | 2010-09-01 | 2013-06-27 | TONIX Pharmaceuticals Holding Corp | Treatment for cocaine addiction |
WO2013027191A1 (fr) | 2011-08-25 | 2013-02-28 | Novartis Ag | Procédés et compositions utilisant des polypeptides de fusion fgf23 |
US9539201B2 (en) | 2012-04-20 | 2017-01-10 | KAT Transdermals LLC | Selegiline transdermal system |
AU2015356643B2 (en) | 2014-12-04 | 2019-01-24 | Novartis Ag | Methods and compositions using Klotho variant polypeptides |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4868218A (en) * | 1987-08-18 | 1989-09-19 | Buyske Donald A | Method of treating depression |
US5444095A (en) * | 1991-04-04 | 1995-08-22 | University Of Toronto, Innovations Foundation | Use of deprenyl to rescue damaged nerve cells |
CA2107552C (fr) * | 1991-04-04 | 2001-08-28 | William G. Tatton | Utilisation du deprenyl pour le maintien, la prevention de la perte et la recuperation de la fonction nerveuse |
-
1997
- 1997-03-13 CN CN97193059A patent/CN1116870C/zh not_active Expired - Fee Related
- 1997-03-13 CA CA002244253A patent/CA2244253C/fr not_active Expired - Fee Related
- 1997-03-13 AU AU23397/97A patent/AU709323B2/en not_active Ceased
- 1997-03-13 US US09/402,752 patent/US6239181B1/en not_active Expired - Fee Related
- 1997-03-13 WO PCT/US1997/004584 patent/WO1997033572A1/fr active Application Filing
- 1997-03-13 JP JP53292997A patent/JP3258027B2/ja not_active Expired - Fee Related
- 1997-03-13 EP EP97916143A patent/EP0906090A1/fr not_active Ceased
-
1999
- 1999-07-23 HK HK99103182A patent/HK1018204A1/xx not_active IP Right Cessation
-
2001
- 2001-05-25 US US09/865,991 patent/US6500868B2/en not_active Expired - Fee Related
-
2002
- 2002-08-21 US US10/225,522 patent/US6538036B2/en not_active Expired - Fee Related
-
2003
- 2003-03-19 US US10/392,797 patent/US6743824B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20010023260A1 (en) | 2001-09-20 |
AU709323B2 (en) | 1999-08-26 |
CN1213300A (zh) | 1999-04-07 |
EP0906090A1 (fr) | 1999-04-07 |
US6538036B2 (en) | 2003-03-25 |
US6239181B1 (en) | 2001-05-29 |
JPH11507951A (ja) | 1999-07-13 |
CA2244253C (fr) | 2002-11-12 |
US20030013771A1 (en) | 2003-01-16 |
CA2244253A1 (fr) | 1997-09-18 |
US6743824B2 (en) | 2004-06-01 |
AU2339797A (en) | 1997-10-01 |
US6500868B2 (en) | 2002-12-31 |
JP3258027B2 (ja) | 2002-02-18 |
CN1116870C (zh) | 2003-08-06 |
US20030181529A1 (en) | 2003-09-25 |
WO1997033572A1 (fr) | 1997-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1018204A1 (en) | A use of selegiline in the manufacture of a medicament for preventing or treating peripheral neuropathy | |
HRP960365B1 (en) | New medicaments and the use thereof | |
GB9411080D0 (en) | Treatment | |
GB2276639B (en) | Solutions for wood treatment and their preparation | |
GB9416798D0 (en) | Delivery valve | |
AU5127098A (en) | Use of a combination of penciclovir and alpha-interferon in the manufacture of a medicament for the treatment of hepatitis | |
HUP0001063A3 (en) | Use of green porphyrins in the manufacture of a medicament treating atherosclerosis | |
IL119894A (en) | Use of thiazolidine in the preparation of a medicament for the treatment of osteoporosis | |
HK1022269A1 (en) | Use of 1-hydroxy-2-pyridones in the manufacture of a medicament for treating skin infections | |
HK1001286A1 (en) | Benzopyrans and their use as therapeutic agents. | |
IL112602A0 (en) | N,n-dimethyl-1-Ú1-(4-chlorophenyl)cyclobutyl¾-3-methylbutylamine in the treatment of epilepsy | |
ZA935575B (en) | Therapeutic agent and its use. | |
GB2319729B (en) | A film for topical use in the treatment of wounds | |
GB9411045D0 (en) | Compounds and use | |
HU9402578D0 (en) | Medicament for treating or preventing cerebrovascular diseases | |
GB2294646B (en) | Material treatment | |
EP0698361A3 (fr) | Lit anti-escarres | |
GB9415900D0 (en) | Novel compounds and treatment | |
ZA984585B (en) | Use of a pharmaceutical composition in the treatment of taumatic arthritis in horses | |
CA2248753A1 (fr) | Utilisation de l'olanzapine pour le traitement de l'agressivite excessive | |
HUP0003908A3 (en) | Use of substituted azaspirane in the manufacture of a medicament for use in treating asthma | |
GB9719076D0 (en) | A material for producing a medical dressing and a medical dressing produced using the material | |
GB9518064D0 (en) | Delivery valves | |
GB2292878B (en) | Footwear and the manufacture thereof | |
IL130103A0 (en) | The use of a diarylalkane derivative in the manufacture of a medicament for treatment or prevention of pancreatitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20100313 |